Mollugin (1, 5, 25, 50, and 100 μM) was also reported to possess the anti-cancer abilities in HER2-overexpressing cancer cells in a dose- and time-dependent manner with an IC50 value of 50 mM. The gene discussed is ERBB2; the disease is cancer.